Navigation Links
hERG-CHO K1 Recombinant Cell Line from Upstate

ProductshERG-CHO K1 Recombinant Cell Line from Upstate
Company Upstate
Item hERG-CHO K1 Recombinant Cell Line
Price 
Description PrecisION Ion Channel Cell Lines
High Quality, Functionally-Validated, Ion Channel Cell Lines

Ion channels are well known for having a critical role in nerve and muscle function and consequently have a key function in pain, CNS and the heart. Drugs that modulate ion channels have been investigated in therapeutic areas, such as neuropathic pain, cardiac arrhythmia, hypertension, local anaesthesia, stroke, Parkinson's, obesity, epilepsy, diabetes and depression.

Historically, ion channels have been under exploited as drug targets primarily due to the lack of functional high throughput screening technologies. Over recent years, there has been considerable progress in this important area. However, now there is a requirement for high quality research tools that will allow the full benefit of the new screening technologies to be realised. Upstate has built a portfolio of ion channel cell lines to meet these new and evolving needs in the drug discovery industry.

Our ion channel cell lines are available off of the shelf. These cell lines are fully validated using electrophysiology, stable (>25 passage) and licensed for drug discovery research. The objective is to provide the pharmaceutical industry with a range of ion channel cell lines to support drug discovery, lead optimisation and safety pharmacology functions.

Mycoplasma Testing:
The cell line has been screened using the PCR VenorGem kit (Minerva Biolabs) to confirm the absence of Mycoplasma species.
Info UpstateUpstate
28820 Single Oak Drive
Temecula, CA 92590
Customer Service: 800-437-7500 or 951-676-8080
Tech Support: 800 548-7853
Fax Number: 800-437-7502 or 951-676-9209
Web Site: http://www.upstate.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. hERG-CHO K1 Recombinant Cell Line from Upstate
2. Recombinant Expression of Peptides and Proteins: from rPeptide, LLC
3. Recombinant RNasin® Ribonuclease Inhibitor from Promega
4. GeneChoice RNA Safe Recombinant Ribonuclease Inhibitor from GeneChoice, Inc.
5. RNaseOUT Recombinant Ribonuclease Inhibitor from Invitrogen
6. hKv4.2/hKChIP2-CHO K1 Recombinant Cell Line from Upstate
7. hHCN4-CHO K1 Recombinant Cell Line from Upstate
8. hKv1.5-CHO K1 Recombinant Cell Line from Upstate
9. hNav1.6-HEK293 Recombinant Cell Line from Upstate
10. hKvLQT1/hminK-CHO K1 Recombinant Cell Line from Upstate
11. Smac/DIABLO, Human, Recombinant, E. coli from Calbiochem
Component in MasterPure™ Purification Kits...
Mouse monoclonal [TU-20] to beta III Tubulin (FITC) ( Abpromise for all tested applications). entrezGeneID: 10381 SwissProtID: Q13509...
Phospho-FKHR (Thr24)/FKHRL1 (Thr32) Antibody...
Mouse anti-Insulin-Like-3 Class: Antibody Product Group: Adipokine and Obesity related...
Biology Products:
(Date:10/10/2019)... ... 10, 2019 , ... Mindray, a global developer of technologies ... Society of Anesthesiologists 2019 Annual Meeting to visit exhibit #841 and discover the ... and will provide more than 14,000 healthcare professionals from around the world the ...
(Date:10/8/2019)... ... 07, 2019 , ... The future of medicine in the 21st century will ... living longer, healthier lives. But it will be up to each individual to make ... PhD, Chief Strategy Officer and Co-Founder of the Institute for Systems Biology and Senior ...
(Date:10/3/2019)... Calif. (PRWEB) , ... October 02, 2019 , ... ... enrolled the first patient in an FDA approved clinical trial for stem cell ... one year after formation of the company as a subsidiary of VetStem Biopharma. , ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... BOSTON (PRWEB) , ... October 03, 2019 , ... Yesterday, ... 2-3, Asymmetrex founder and director, James L. Sherley, M.D., Ph.D., discussed important ... To an attendee audience including both developers and suppliers of clinical trials, in ...
(Date:9/24/2019)... LAFAYETTE, Ind. (PRWEB) , ... ... ... LLC will be presenting their latest research in the area of high-level ... November 4th, Dr. Pamela Smith, COO of Improved Pharma, will present “Synchrotron ...
(Date:9/24/2019)... SOMERSET, N.J. and WALTHAM, Mass. (PRWEB) , ... ... ... Catalent, the leading global provider of advanced delivery technologies, development, and ... Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the ...
(Date:9/24/2019)... , ... September 24, 2019 , ... ... Hannah Holscher, PhD, RD, to its Scientific Advisory Board. Dr. Holscher is an ... and the Division of Nutritional Sciences at the University of Illinois Urbana-Champaign, where ...
Breaking Biology Technology: